Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) ...

Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing ...

A panelist discusses how second-line treatment options for kidney cancer have evolved through multiple clinical trials ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue.

Cancer patients face more than just the disease. They spend countless hours commuting, waiting, and undergoing treatment.

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

A Milford family is speaking out to honor their daughter and sister gone too soon, and to raise awareness of pediatric ...